# Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss

> **NCT06355856** · PHASE4 · UNKNOWN · sponsor: **Ache Laboratorios Farmaceuticos S.A.** · enrollment: 196 (estimated)

## Conditions studied

- Alopecia

## Interventions

- **DRUG:** DNN.22.17.036
- **DRUG:** 10573048700

## Key facts

- **NCT ID:** NCT06355856
- **Lead sponsor:** Ache Laboratorios Farmaceuticos S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04
- **Primary completion:** 2025-05
- **Final completion:** 2025-05
- **Target enrollment:** 196 (ESTIMATED)
- **Last updated:** 2024-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06355856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06355856, "Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06355856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*